TAIWAN ETF COMPARISON

00897 vs 00919

Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF compared with CAPITAL TIP CUSTOMIZED TAIWAN SELECT HIGH DIVIDEND EXCHANGE TRADED FUND.

Four ways to read this comparison

Portfolio similarity, historical return, distribution yield and annual fund cost answer different questions.

Portfolio overlap0.00%Low · 0 common securities
Higher 1-year return00897+53.23% vs +46.28%
Higher distribution yield00919— vs 12.44%
Lower annual fee009191.05% vs 0.33%

Price and return trend

Normalized returns make funds with different unit prices comparable. Switch to price mode to view actual TWD prices.

00897-2.69%13.04 TWD・-0.36 TWD
00919-10.31%27.49 TWD・-3.16 TWD

Key metrics

Metric00897
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF
00919
CAPITAL TIP CUSTOMIZED TAIWAN SELECT HIGH DIVIDEND EXCHANGE TRADED FUND
Latest closeTWD 13.04TWD 27.49
Assets under managementTWD 1.6BTWD 572.6B
Beneficiaries11,9201,523,591
Trailing 12-month distribution yield—12.44%
Total expense ratio——
Management fee0.85%0.30%
Custody fee0.20%0.04%

Performance and risk

Metric0089700919
1-year return+53.23%+46.28%
3-year return+95.50%+69.19%
5-year return-6.32%—
1-year volatility29.88%20.86%
1-year max drawdown-13.01%-16.75%
1-year Sharpe ratio1.831.4

Returns are price returns. Risk statistics use the available one-year price history and are shown only when sufficient observations exist.

Sector allocation

Weights are based on the latest available disclosed portfolios.

Sector0089700919
Financials
0.00%
54.12%
Computers & Peripherals
0.00%
17.52%
Transportation
0.00%
7.81%
Semiconductors
0.00%
6.11%
Construction
0.00%
2.53%
Other
0.00%
1.80%
Textiles
0.00%
1.59%
Electronics Distribution
0.00%
1.24%
Sports & Leisure
0.00%
1.14%
Other Electronics
0.00%
0.93%
Electronic Components
0.00%
0.81%
Rubber
0.00%
0.61%

Common holdings

0 securities appear in both disclosed portfolios. Data updated Nov 20, 2026.

No data is currently available.

Holdings unique to each ETF

These securities appear in one disclosed portfolio but not the other.

#Security00897 weight
1MRNA · MODERNA INC12.84%
2GMAB · GENMAB A/S6.36%
3TWST · TWIST BIOSCIENCE CORP4.93%
4REGN · REGENERON PHARMACEUTICALS INC4.44%
5BAYN · Bayer AG4.38%
64502 · Takeda Pharmaceutical Co Ltd4.32%
7EXEL · EXELIXIS INC3.82%
8VRTX · VERTEX PHARMACEUTICALS INC3.56%
9ROP · ROCHE HOLDING AG3.51%
10INCY · INCYTE CORP3.46%
11MRK · MERCK & CO INC3.36%
12RVMD · REVOLUTION MEDICINES INC3.26%
13SAN · SANOFI3.12%
14IPN · IPSEN2.98%
15GSK · GSK PLC2.83%
16BNTX · BIONTECH SE2.82%
17IOVA · IOVANCE BIOTHERAPEUTICS INC2.72%
18IBRX · IMMUNITYBIO INC2.37%
19ABCL · ABCELLERA BIOLOGICS INC2.36%
20CAI · CARIS LIFE SCIENCES INC2.18%
21IDYA · IDEAYA BIOSCIENCES INC2.09%
224528 · ONO PHARMACEUTICAL CO LTD1.70%
23RCUS · ARCUS BIOSCIENCES INC1.27%
24NVAX · NOVAVAX INC1.16%
25VIR · VIR BIOTECHNOLOGY INC1.13%

Fund profile and disclosure dates

Metric0089700919
IssuerFubon Asset ManagementCapital Investment Trust
Tracking index / benchmark——
Listing dateOct 4, 2021Oct 20, 2022
Latest market dateNov 20, 2026Nov 20, 2026
Holdings dateNov 19, 2026Nov 20, 2026
Eligible stock positions4740
Premium / discount-0.61%+0.18%

Switching estimate

Estimate how many units of the other ETF the current market value could purchase.

0089700919
Current market valueTWD 130.4K
Unrealized gain / lossTWD 0
Estimated 00919 units4,743
Estimated annual distribution changeTWD 16.2K

This estimate excludes brokerage fees, taxes, bid-ask spreads and intraday price movement.

Continue researching this pair

Review each ETF independently or open another published comparison.

Taiwan ETF comparison FAQ

What does portfolio overlap measure?

For each common security, ETF Info takes the smaller of the two portfolio weights and adds those amounts. A higher percentage indicates more similar disclosed stock allocation.

Are historical returns shown with distributions?

Use the label shown for each metric. The long-period return fields are based on the return dataset, while the interactive price chart shows price returns and excludes distributions.

Can the lower-fee or higher-return ETF be considered the winner?

No single metric determines suitability. Fees, risk, liquidity, tracking exposure, distributions and portfolio construction answer different questions.

How to use this comparison

Fees, historical returns and overlap answer different questions. Portfolio overlap shows how similar the latest disclosed holdings are; it does not predict future performance or account for every trading cost, tax or distribution policy.